Search

AngioDynamics Inc

Abierto

SectorSanidad

14 -0.43

Resumen

Variación precio

24h

Actual

Mínimo

13.83

Máximo

14.28

Métricas clave

By Trading Economics

Ingresos

-3.3M

-11M

Ventas

8.2M

87M

BPA

-0.07

Margen de beneficios

-13.169

Empleados

632

EBITDA

-26M

-28M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+47.68% upside

Dividendos

By Acuity

Próximas Ganancias

1 oct 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

38M

567M

Apertura anterior

14.43

Cierre anterior

14

Noticias sobre sentimiento de mercado

By Acuity

100%

0%

323 / 340 Clasificación en Healthcare

AngioDynamics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

21 jul 2026, 20:06 UTC

News

AngioDynamics Inc shares are higher today, supported by a strong Nasdaq 100 Index. Analysts maintain a Hold rating amid optimism for NanoKnife technology.

20 jul 2026, 19:46 UTC

News

AngioDynamics shares are higher today, despite a downgrade to "strong sell" from Zacks Research and a price target increase from Canaccord Genuity to $20.00.

Comparación entre iguales

Cambio de precio

AngioDynamics Inc previsión

Precio Objetivo

By TipRanks

47.68% repunte

Estimación a 12 Meses

Media 21 USD  47.68%

Máximo 24 USD

Mínimo 19 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para AngioDynamics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

3 ratings

3

Comprar

0

Mantener

0

Vender

Sentimiento

By Acuity

323 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.